Ubiquitin signalling in the NF-κB pathway (original) (raw)
Hershko, A., Ciechanover, A. & Rose, I. A. Resolution of the ATP-dependent proteolytic system from reticulocytes: a component that interacts with ATP. Proc. Natl Acad. Sci USA76, 3107–3110 (1979). ArticleCASPubMedPubMed Central Google Scholar
Ciechanover, A., Heller, H., Elias, S., Haas, A. L. & Hershko, A. ATP-dependent conjugation of reticulocyte proteins with the polypeptide required for protein degradation. Proc. Natl Acad. Sci. USA77, 1365–1368 (1980). ArticleCASPubMedPubMed Central Google Scholar
Sen, R. & Baltimore, D. Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell46, 705–716 (1986). ArticleCASPubMed Google Scholar
Sen, R. & Baltimore, D. Inducibility of κ immunoglobulin enhancer-binding protein NF-κB by a posttranslational mechanism. Cell47, 921–928 (1986). ArticleCASPubMed Google Scholar
Baeuerle, P. A. & Baltimore, D. Activation of DNA-binding activity in an apparently cytoplasmic precursor of the NF-κB transcription factor. Cell53, 211–217 (1988). ArticleCASPubMed Google Scholar
Palombella, V. J., Rando, O. J., Goldberg, A. L. & Maniatis, T. The ubiquitin-proteasome pathway is required for processing the NF-κB1 precursor protein and the activation of NF-κB. Cell78, 773–785 (1994). ArticleCASPubMed Google Scholar
Chen, Z. et al. Signal-induced site-specific phosphorylation targets IκBα to the ubiquitin-proteasome pathway. Genes Dev.9, 1586–97 (1995). ArticleCASPubMed Google Scholar
Chen, Z. & Maniatis, T. Role of the Ubiquitin-Proteasome Pathway in NF-κB Activation. 303–22 (Plenum Press, New York, 1998). Google Scholar
Chen, Z. J., Parent, L. & Maniatis, T. Site-specific phosphorylation of IκBα by a novel ubiquitination-dependent protein kinase activity. Cell84, 853–862 (1996). ArticleCASPubMed Google Scholar
Deng, L. et al. Activation of the IκB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain. Cell103, 351–361 (2000). ArticleCASPubMed Google Scholar
Wang, C. et al. TAK1 is a ubiquitin-dependent kinase of MKK and IKK. Nature412, 346–351 (2001). ArticleCASPubMed Google Scholar
Deng, L. & Chen, Z. Role of Ubiquitin in NF-κB Signaling. 139–160 (Kluwer, Boston, 2003). Google Scholar
Ben-Neriah, Y. Regulatory functions of ubiquitination in the immune system. Nature Immunol.3, 20–26 (2002). ArticleCAS Google Scholar
Li, Q. & Verma, I. M. NF-κB regulation in the immune system. Nature Rev. Immunol.2, 725–734 (2002). ArticleCAS Google Scholar
Xiao, G., Harhaj, E. W. & Sun, S. C. NF-κB-inducing kinase regulates the processing of NF-κB2 p100. Mol. Cell7, 401–409 (2001). ArticleCASPubMed Google Scholar
Senftleben, U. et al. Activation by IKKα of a second, evolutionary conserved, NF-κB signaling pathway. Science293, 1495–1499 (2001). ArticleCASPubMed Google Scholar
Chau, V. et al. A multiubiquitin chain is confined to specific lysine in a targeted short-lived protein. Science243, 1576–1583 (1989). ArticleCASPubMed Google Scholar
Peng, J. et al. A proteomics approach to understanding protein ubiquitination. Nature Biotechnol.21, 921–926 (2003). ArticleCAS Google Scholar
Alkalay, I. et al. Stimulation-dependent IκBα phosphorylation marks the NF-κB inhibitor for degradation via the ubiquitin-proteasome pathway. Proc. Natl Acad. Sci. USA92, 10599–10603 (1995). ArticleCASPubMedPubMed Central Google Scholar
Margottin, F. et al. A novel human WD protein, h-βTrCp, that interacts with HIV-1 Vpu connects CD4 to the ER degradation pathway through an F-box motif. Mol. Cell1, 565–574 (1998). ArticleCASPubMed Google Scholar
Winston, J. T. et al. The SCFβ–TRCP–ubiquitin ligase complex associates specifically with phosphorylated destruction motifs in IκBα and β-catenin and stimulates IκBα ubiquitination in vitro. Genes Dev.13, 270–283 (1999). ArticleCASPubMedPubMed Central Google Scholar
Yaron, A. et al. Identification of the receptor component of the IκBα-ubiquitin ligase. Nature396, 590–594 (1998). ArticleCASPubMed Google Scholar
Spencer, E., Jiang, J. & Chen, Z. J. Signal-induced ubiquitination of IκBα by the F-box protein Slimb/β–TrCP. Genes Dev.13, 284–294 (1999). ArticleCASPubMedPubMed Central Google Scholar
Jiang, J. & Struhl, G. Regulation of the Hedgehog and Wingless signalling pathways by the F-box/WD40-repeat protein Slimb. Nature391, 493–496 (1998). ArticleCASPubMed Google Scholar
Guardavaccaro, D. et al. Control of meiotic and mitotic progression by the F box protein β-Trcp1 in vivo. Dev. Cell4, 799–812 (2003). ArticleCASPubMed Google Scholar
Lin, L., DeMartino, G. N. & Greene, W. C. Cotranslational biogenesis of NF-κB p50 by the 26S proteasome. Cell92, 819–828 (1998). ArticleCASPubMed Google Scholar
Ciechanover, A. et al. Mechanisms of ubiquitin-mediated, limited processing of the NF-κB1 precursor protein p105. Biochimie83, 341–349 (2001). ArticleCASPubMed Google Scholar
Amir, R. E., Haecker, H., Karin, M. & Ciechanover, A. Mechanism of processing of the NF-κB2 p100 precursor: identification of the specific polyubiquitin chain-anchoring lysine residue and analysis of the role of NEDD8-modification on the SCF(β-TrCP) ubiquitin ligase. Oncogene23, 2540–2547 (2004). ArticleCASPubMed Google Scholar
Fong, A. & Sun, S. C. Genetic evidence for the essential role of β-transducin repeat-containing protein in the inducible processing of NF-κB2/p100. J. Biol. Chem.277, 22111–22114 (2002). ArticleCASPubMed Google Scholar
Rape, M. & Jentsch, S. Productive RUPture: activation of transcription factors by proteasomal processing. Biochim. Biophy.s Acta1695, 209–213 (2004). ArticleCAS Google Scholar
Lin, L. & Ghosh, S. A glycine-rich region in NF-κB p105 functions as a processing signal for the generation of the p50 subunit. Mol. Cell. Biol.16, 2248–2254 (1996). ArticleCASPubMedPubMed Central Google Scholar
Chung, J. Y., Park, Y. C., Ye, H. & Wu, H. All TRAFs are not created equal: common and distinct molecular mechanisms of TRAF-mediated signal transduction. J. Cell Sci.115, 679–688 (2002). CASPubMed Google Scholar
Chen, G. & Goeddel, D. V. TNF-R1 signaling: a beautiful pathway. Science296, 1634–1635 (2002). ArticleCASPubMed Google Scholar
Lomaga, M. A. et al. TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling. Genes Dev.13, 1015–1024 (1999). ArticleCASPubMedPubMed Central Google Scholar
Naito, A. et al. Severe osteopetrosis, defective interleukin-1 signalling and lymph node organogenesis in TRAF6-deficient mice. Genes Cells4, 353–362 (1999). ArticleCASPubMed Google Scholar
Hofmann, R. M. & Pickart, C. M. Noncanonical MMS2-encoded ubiquitin-conjugating enzyme functions in assembly of novel polyubiquitin chains for DNA repair. Cell96, 645–653 (1999). ArticleCASPubMed Google Scholar
Ninomiya-Tsuji, J. et al. The kinase TAK1 can activate the NIK-IκB as well as the MAP kinase cascade in the IL-1 signalling pathway. Nature398, 252–256 (1999). ArticleCASPubMed Google Scholar
Kanayama, A. et al. TAB2 and TAB3 activate the NF-κB pathway through binding to polyubiquitin chains. Mol Cell15, 535–548 (2004). ArticleCASPubMed Google Scholar
Varadan, R. et al. Solution conformation of Lys63-linked di-ubiquitin chain provides clues to functional diversity of polyubiquitin signaling. J. Biol. Chem.279, 7055–7063 (2004). ArticleCASPubMed Google Scholar
Shi, C. S. & Kehrl, J. H. Tumor necrosis factor (TNF)-induced germinal center kinase-related (GCKR) and stress-activated protein kinase (SAPK) activation depends upon the E2/E3 complex Ubc13-Uev1A/TNF receptor-associated factor 2 (TRAF2). J. Biol. Chem.278, 15429–15434 (2003). ArticleCASPubMed Google Scholar
Xia, Z. P. & Chen, Z. J. TRAF2: a double-edged sword? Sci. STKE2005, pe7 (2005). PubMed Google Scholar
Habelhah, H. et al. Ubiquitination and translocation of TRAF2 is required for activation of JNK but not of p38 or NF-κB. EMBO J.23, 322–332 (2004). ArticleCASPubMedPubMed Central Google Scholar
Yeh, W. C. et al. Early lethality, functional NF-κB activation, and increased sensitivity to TNF-induced cell death in TRAF2-deficient mice. Immunity7, 715–725 (1997). ArticleCASPubMed Google Scholar
Tada, K. et al. Critical roles of TRAF2 and TRAF5 in tumor necrosis factor-induced NF-κB activation and protection from cell death. J. Biol. Chem.276, 36530–36534 (2001). ArticleCASPubMed Google Scholar
Lee, T. H., Shank, J., Cusson, N. & Kelliher, M. A. The kinase activity of Rip1 is not required for tumor necrosis factor-alpha-induced IκB kinase or p38 MAP kinase activation or for the ubiquitination of Rip1 by Traf2. J. Biol. Chem.279, 33185–33191 (2004). ArticleCASPubMed Google Scholar
Zhang, S. Q., Kovalenko, A., Cantarella, G. & Wallach, D. Recruitment of the IKK signalosome to the p55 TNF receptor: RIP and A20 bind to NEMO (IKKγ) upon receptor stimulation. Immunity12, 301–311 (2000). ArticleCASPubMed Google Scholar
Legler, D. F., Micheau, O., Doucey, M. A., Tschopp, J. & Bron, C. Recruitment of TNF receptor 1 to lipid rafts is essential for TNFα-mediated NF-κB activation. Immunity18, 655–664 (2003). ArticleCASPubMed Google Scholar
Ninomiya-Tsuji, J. et al. A resorcylic acid lactone, 5Z-7-oxozeaenol, prevents inflammation by inhibiting the catalytic activity of TAK1 MAPK kinase kinase. J. Biol. Chem.278, 18485–18490 (2003). ArticleCASPubMed Google Scholar
Takaesu, G. et al. TAK1 is critical for IκB kinase-mediated activation of the NF-κB pathway. J. Mol. Biol.326, 105–115 (2003). ArticleCASPubMed Google Scholar
Vidal, S. et al. Mutations in the Drosophila dTAK1 gene reveal a conserved function for MAPKKKs in the control of rel/NF-κB-dependent innate immune responses. Genes Dev.15, 1900–1912 (2001). ArticleCASPubMedPubMed Central Google Scholar
Silverman, N. et al. Immune activation of NF-κB and JNK requires Drosophila TAK1. J. Biol. Chem.278, 48928–48934 (2003). ArticleCASPubMed Google Scholar
Chen, W., White, M. A. & Cobb, M. H. Stimulus-specific requirements for MAP3 kinases in activating the JNK pathway. J. Biol. Chem.277, 49105–49110 (2002). ArticleCASPubMed Google Scholar
Sanjo, H. et al. TAB2 is essential for prevention of apoptosis in fetal liver but not for interleukin-1 signaling. Mol. Cell. Biol.23, 1231–1238 (2003). ArticleCASPubMedPubMed Central Google Scholar
Komatsu, Y. et al. Targeted disruption of the Tab1 gene causes embryonic lethality and defects in cardiovascular and lung morphogenesis. Mech. Dev.119, 239–249 (2002). ArticleCASPubMed Google Scholar
Shibuya, H. et al. TAB1: an activator of the TAK1 MAPKKK in TGF-β signal transduction. Science272, 1179–1182 (1996). ArticleCASPubMed Google Scholar
Yamaguchi, K. et al. Identification of a member of the MAPKKK family as a potential mediator of TGF-β signal transduction. Science270, 2008–2011 (1995). ArticleCASPubMed Google Scholar
Vadlamudi, R. K., Joung, I., Strominger, J. L. & Shin, J. p62, a phosphotyrosine-independent ligand of the SH2 domain of p56lck, belongs to a new class of ubiquitin-binding proteins. J. Biol. Chem.271, 20235–20237 (1996). ArticleCASPubMed Google Scholar
Sanz, L., Sanchez, P., Lallena, M. J., Diaz-Meco, M. T. & Moscat, J. The interaction of p62 with RIP links the atypical PKCs to NF-κB activation. EMBO J.18, 3044–3053 (1999). ArticleCASPubMedPubMed Central Google Scholar
Sanz, L., Diaz-Meco, M. T., Nakano, H. & Moscat, J. The atypical PKC-interacting protein p62 channels NF-κB activation by the IL-1–TRAF6 pathway. EMBO J.19, 1576–1586 (2000). ArticleCASPubMedPubMed Central Google Scholar
Duran, A. et al. The atypical PKC-interacting protein p62 is an important mediator of RANK-activated osteoclastogenesis. Dev. Cell6, 303–309 (2004). ArticleCASPubMed Google Scholar
Huang, Q. et al. Differential regulation of interleukin 1 receptor and Toll-like receptor signaling by MEKK3. Nature Immunol.5, 98–103 (2004). ArticleCAS Google Scholar
Yang, J. et al. The essential role of MEKK3 in TNF-induced NF-κB activation. Nature Immunol.2, 620–624 (2001). ArticleCAS Google Scholar
Thome, M. & Tschopp, J. TCR-induced NF-κB activation: a crucial role for Carma1, Bcl10 and MALT1. Trends Immunol.24, 419–424 (2003). ArticleCASPubMed Google Scholar
van Oers, N. S. & Chen, Z. J. Cell biology. Kinasing and clipping down the NF-κB trail. Science308, 65–66 (2005). ArticleCASPubMed Google Scholar
Zhou, H. et al. Bcl10 activates the NF-κB pathway through ubiquitination of NEMO. Nature427, 167–171 (2004). ArticleCASPubMed Google Scholar
Sun, L., Deng, L., Ea, C. K., Xia, Z. P. & Chen, Z. J. The TRAF6 ubiquitin ligase and TAK1 kinase mediate IKK activation by BCL10 and MALT1 in T lymphocytes. Mol. Cell14, 289–301 (2004). ArticleCASPubMed Google Scholar
Huang, T. T., Wuerzberger-Davis, S. M., Wu, Z. H. & Miyamoto, S. Sequential modification of NEMO/IKKγ by SUMO-1 and ubiquitin mediates NF-κB activation by genotoxic stress. Cell115, 565–576 (2003). ArticleCASPubMed Google Scholar
Inohara, N. & Nunez, G. NODs: intracellular proteins involved in inflammation and apoptosis. Nature Rev. Immunol.3, 371–382 (2003). ArticleCAS Google Scholar
Abbott, D. W., Wilkins, A., Asara, J. M. & Cantley, L. C. The Crohn's disease protein, NOD2, requires RIP2 in order to induce ubiquitinylation of a novel site on NEMO. Curr. Biol.14, 2217–2227 (2004). ArticleCASPubMed Google Scholar
Maeda, S. et al. Nod2 mutation in Crohn's disease potentiates NF-κB activity and IL-1β processing. Science307, 734–738 (2005). ArticleCASPubMed Google Scholar
Kawai, T. et al. Interferon-α induction through Toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6. Nature Immunol.5, 1061–8 (2004). ArticleCAS Google Scholar
Brummelkamp, T. R., Nijman, S. M., Dirac, A. M. & Bernards, R. Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-κB. Nature424, 797–801 (2003). ArticleCASPubMed Google Scholar
Kovalenko, A. et al. The tumour suppressor CYLD negatively regulates NF-κB signalling by deubiquitination. Nature424, 801–805 (2003). ArticleCASPubMed Google Scholar
Trompouki, E. et al. CYLD is a deubiquitinating enzyme that negatively regulates NF-κB activation by TNFR family members. Nature424, 793–796 (2003). ArticleCASPubMed Google Scholar
Reiley, W., Zhang, M. & Sun, S. C. Negative regulation of JNK signaling by the tumor suppressor CYLD. J. Biol. Chem.279, 55161–55167 (2004). ArticleCASPubMed Google Scholar
Boone, D. L. et al. The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses. Nature Immunol.5, 1052–1060 (2004). ArticleCAS Google Scholar
Wertz, I. E. et al. De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-κB signalling. Nature430, 694–699 (2004). ArticleCASPubMed Google Scholar
Evans, P. C. et al. Zinc-finger protein A20, a regulator of inflammation and cell survival, has de-ubiquitinating activity. Biochem. J.378, 727–734 (2004). ArticleCASPubMedPubMed Central Google Scholar
Wang, Y. Y., Li, L., Han, K. J., Zhai, Z. & Shu, H. B. A20 is a potent inhibitor of TLR3- and Sendai virus-induced activation of NF-κB and ISRE and IFN-β promoter. FEBS Lett.576, 86–90 (2004). ArticleCASPubMed Google Scholar